Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
aav2cuhcln2 (1 trial)
Neuronal Ceroid-Lipofuscinoses (Phase 1)
Trials (1 total)
Trial APIs (1 total)